جستجوی استاد راهنمای دانشگاهی

Gonzalo Guillén Gosálbezمشاهده پروفایل

استاد

• Process Systems Engineering
• Sustainable Chemistry
• Environmental Impact Assessment
• +۷ مورد دیگر

Prof. Dr. Gonzalo Guillén Gosálbez is a Full Professor at the Department of Chemistry and Applied Biosciences , ETH Zürich. He holds a PhD in Process Systems Engineering (UPC, 2005) and has held academic positions at Imperial College London (Reader), University of Manchester (Senior Lecturer), and Universitat Rovira i Virgili (Assistant/Associate Professor). His research focuses on Sustainable Chemical Processes , integrating life cycle assessment, optimization techniques, and planetary boundary analysis to evaluate and design low-carbon technologies. Current position: Full Professor, ETH Zürich (2019–present) Prior roles: Imperial College London (2016–2019), University of Manchester (2014–2016), URV Spain (2008–2014) Education: PhD (UPC, 2005), MEng/BEng (University of Murcia) His research explores CO2 valorization , green methanol synthesis , circular marine fuels , and planetary boundary compliance in energy and chemical systems. Recent work emphasizes machine learning for process modeling, single-atom catalysis , and decentralized ammonia production . Scientific contributions include 15+ peer-reviewed articles (2023–2025) in journals like Nature Chemical Engineering , ACS Sustainable Chemistry & Engineering , and Energy & Environmental Science . Key themes: Optimization of hybrid fossil/renewable carbon systems Environmental impacts of energy transitions Catalyst design for sustainable chemistry Life cycle assessment of emerging technologies Awarded UPC Top Doctoral Student Award and Top National Student Award , he combines process systems engineering with sustainability metrics to address global challenges in chemical and energy systems.

John M. Woodleyمشاهده پروفایل

استاد

• Biocatalysis
• Bioprocess Engineering
• Enzyme Technology
• +۶ مورد دیگر

John M. Woodley is a distinguished Professor in the Department of Chemical and Biochemical Engineering at the Technical University of Denmark (DTU), where he leads research at the PROSYS - Process and Systems Engineering Centre and contributes to the DTU Microbes Initiative. With over 30 years of experience, he has established himself as a leading expert in biocatalysis and bioprocess engineering, with research spanning both theoretical and experimental work across multiple scales. His primary research interests focus on the interface of bioprocess engineering, process chemistry, and reaction engineering. Dr. Woodley's work encompasses multi-step biocatalysis (including systems biocatalysis and flow chemistry), downstream processing from biocatalytic reactors and fermentations (including ISPR), modeling tools for bioprocess assessment (thermodynamics, kinetics, process simulation, economic evaluation), and bio-oxidations (including oxygen supply methods). His enzymatic investigations particularly target alcohol oxidases, carbohydrate oxidases, cytochrome P450s, Baeyer-Villiger monooxygenases, and transaminases. His research portfolio demonstrates consistent innovation in sustainable chemical production, with particular emphasis on enzymatic synthesis of pharmaceuticals and chemicals from renewable resources. Analysis of his recent publications reveals a strong focus on overcoming industrial implementation challenges, particularly regarding enzyme stability in various reactor environments, optimization of multi-enzyme systems, and scale-up methodologies for biocatalytic processes. Dr. Woodley actively supervises multiple PhD students and leads several significant research projects, including 'P450-based biocatalytic processes for the pharmaceutical industry' (2025-2028), 'Integrated model for up- and downstream bioprocess intensification' (2024-2027), and 'ENFACE: A tool for prediction of enzyme stability at gas-liquid interfaces' (2024-2027). His work has resulted in an impressive publication record of 781 research outputs across various formats, including journal articles, book chapters, and conference proceedings. His research group operates within the Department of Chemical and Biochemical Engineering at DTU, utilizing advanced facilities for biocatalysis research, including specialized reactor systems for studying gas-liquid interfaces, computational modeling resources, and laboratories for enzyme characterization and bioprocess development. Through his leadership in the PROSYS center, he contributes to DTU's strategic focus on sustainable process technologies and systems engineering.

Karl Griswoldمشاهده پروفایل

استاد

• Protein engineering
• Directed evolution
• Biotherapeutics
• +۲ مورد دیگر

Karl Griswold is a Professor of Engineering at Dartmouth College's Thayer School of Engineering, where he leads the Griswold Research Group focused on protein engineering and biotherapeutics development. His interdisciplinary work spans chemical, biological, and engineering disciplines to address critical challenges in drug-resistant infections and protein therapeutics. Education: BS in Chemistry from Southwest Texas State University (1995) PhD in Chemistry from the University of Texas at Austin (2005) Research Focus: Professor Griswold's laboratory specializes in protein engineering, directed evolution, and biotherapeutics development , creating novel biomolecules with superior functionality compared to natural proteins. The group develops high-throughput screening methods, protein deimmunization strategies, enhanced expression systems, and antibacterial agents targeting drug-resistant infections. Their work has significant translational potential for treating conditions like MRSA and Pseudomonas aeruginosa infections. Scientific Recognition: Wallace H. Coulter Foundation Early Career Translational Research Award in Biomedical Engineering (2008) NIH Biotechnology Training Grant (2000-2003) Royston M. Roberts - Regents Fellowship, University of Texas (1999) DOW Chemical Foundation Scholar, Texas State University (1991-1995) Senior Fellow, National Academy of Inventors Research Leadership: As co-founder and CEO of Stealth Biologics, Professor Griswold translates academic research into commercial applications. His work has secured NIH funding and Dartmouth Innovations Accelerator support, with research featured in Chemical & Engineering News, Vermont Public Radio, and the New Hampshire Union Leader for developing alternatives to traditional antibiotics. Research Environment: The Griswold Research Group maintains extensive collaborations across disciplines including clinical medicine, immunology, structural biology, and chemical engineering. This interdisciplinary approach prepares trainees for careers at the intersection of multiple scientific fields, with research focusing on Biomolecular Antimicrobial Therapies, Deimmunizing Protein Therapeutics, and Gene Library Construction Technologies.

C. Perry Chouمشاهده پروفایل

استاد

• biochemical engineering
• bioprocessing
• biomanufacturing
• +۷ مورد دیگر

C. Perry Chou is a full professor in the Chemical Engineering Department at the University of Waterloo, with a cross-appointment in Biology. He holds a BSc and MSc from National Taiwan University and a PhD from Rice University, all in Chemical Engineering. His research focuses on integrating biochemical, genetic, and metabolic engineering strategies to enhance biomanufacturing using microbial cell factories. Key areas include recombinant protein production, microbial biotechnology, and biofuel development. Education: PhD in Chemical Engineering, Rice University (1995) MSc in Chemical Engineering, National Taiwan University (1987) BSc in Chemical Engineering, National Taiwan University (1984) Research Interests: Dr. Chou’s work spans biochemical engineering, bioprocessing, and metabolic engineering. He develops strategies for microbial strain construction, fermentation optimization, and bioproduct purification. His research bridges fundamental biological sciences with applied engineering to advance biomanufacturing. Publications: His 90+ peer-reviewed articles highlight contributions to strain engineering, CRISPR-Cas9 tools, and microbial production of chemicals like 5-aminolevulinic acid and propionate. Recent trends emphasize nanomaterial applications (e.g., graphene oxide) and sustainable biofuel pathways. Awards: Canada Research Chair (Canada) 1000-talent Award (China) Advising & Grants: Dr. Chou actively mentors graduate students and contributes to editorial roles at journals like Biotechnology Advances and Scientific Reports . He teaches courses such as CHE 161 (Engineering Biology) and CHE 562 (Advanced Bioprocess Engineering). Labs/Teams: Collaborates with interdisciplinary teams to advance bioprocess development, though specific lab names are not explicitly mentioned in the text.

Jennifer Lewisمشاهده پروفایل

استاد

• Bioengineering
• Materials Science
• Soft Matter
• +۷ مورد دیگر

Jennifer Lewis is the Hansjorg Wyss Professor of Biologically Inspired Engineering and Jianming Yu Professor of Arts and Sciences at Harvard University's Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS). Her research focuses on bioengineering, materials science, and advanced manufacturing, with emphasis on 3D-printed functional materials, organoids, and soft robotics. She leads the Lewis Research Group, which develops biomimetic technologies for regenerative medicine, energy systems, and robotics. Lewis holds appointments in SEAS, the Department of Chemistry and Chemical Biology, and the Wyss Institute for Biologically Inspired Engineering. Her research areas include applied mathematics, fluid mechanics, soft matter physics, and bioengineering applications such as kidney organoid models, vascularized tissues, and programmable materials. Notable innovations include kidney organoid-on-chip systems for drug testing, 3D-printed liquid crystal elastomers, and bioprinted cardiac tissues. Lewis was awarded the 2025 James Prize in Science and Technology Integration for pioneering interdisciplinary research. Her lab's projects span organ building blocks, immune-response modeling in transplanted tissues, and acoustophoretic printing techniques for high-resolution bioprinting. Collaborations include the NIH Somatic Cell Genome Editing Program and industry partnerships for bioprosthetic valve research. She advises on grants totaling over $20M and mentors a multidisciplinary team of postdocs and graduate students in materials science, biomedical engineering, and mechanical engineering. Lewis' lab facilities include the Pierce Hall lab (Cambridge) and Allston SEAS campus, with state-of-the-art 3D printing systems, microfluidics platforms, and bioreactors for organoid culture. Current projects aim to engineer functional human tissues for therapeutic applications and develop smart materials with programmable mechanical/chemical responses.

• Algae Biotechnology
• Marine Biology
• Seagrass Ecology
• +۹ مورد دیگر

Distinguished Professor Peter Ralph is a faculty member at the University of Technology Sydney (UTS), holding the position of Professor of Marine Biology within the Faculty of Science and serving as the Executive Director of the Climate Change Cluster (C3). He is also the founder of the NSW Deep Green Biotech Hub and an influential member of global initiatives such as UNESCO’s Blue Carbon Scientific Working Group and the Czech Academy of Sciences’ Global Change Research Centre. Leadership Roles: Director of the Climate Change Cluster, Deputy-Chair of Sydney Institute of Marine Sciences. Research Collaborations: Partnerships with CSIRO, industry, NGOs, and international institutions. Key Contributions: Over 280 publications and $15M+ in research funding. His research focuses on algae-based solutions to climate change and sustainability, including carbon capture, bioplastic production, waste-water remediation, and circular bio-economy models. He explores advanced manufacturing through Industry 4.0 integration and zero-waste bio-refinery approaches, while also advancing algal phenomics using automated high-throughput screening systems. Recent articles highlight innovations in AI-driven biorefinery optimization, microalgal bioprospecting, and mutagenesis techniques for rare earth element extraction. His work bridges environmental science with engineering, addressing challenges in algae cultivation scalability and commercialization. Scientific Awards: 2012 and 2018 UTS Vice-Chancellor’s Research Excellence Awards. Peter has secured major grants, including the Fermentalg PhD Project on Microalgae Screening, PNG Natural Seafood’s Macroalgae Product Development, and the Winifred Trust Foundation’s Aquaculture initiative. His research teams collaborate across disciplines to transform algae into sustainable resources for food, energy, and biomanufacturing. He leads UTS’s Climate Change Cluster (C3), a hub for interdisciplinary climate research, and actively promotes algae-building technologies and carbon storage innovations through biomasonry products.

• Bioprocessing
• Biomedical Engineering
• Bioreactor Engineering
• +۴ مورد دیگر

James M. Piret is a Professor at the University of British Columbia (UBC), affiliated with the School of Biomedical Engineering and the Michael Smith Laboratories. He holds a Sc.D. from MIT (1989), an S.M. from MIT (1986), and an A.B. from Harvard College (1981). His research focuses on bioprocessing, biomedical engineering, and cell therapy biotechnology, with emphasis on optimizing therapeutic cell production and biomanufacturing processes. Education : Sc.D. in Chemical Engineering, Massachusetts Institute of Technology (1989) S.M. in Chemical Engineering, Massachusetts Institute of Technology (1986) A.B. in Chemistry, Harvard College (1981) Professor Piret’s research integrates bioreactor engineering, Raman spectroscopy, and data analytics to advance cell-based therapies for diseases like cancer and diabetes. Collaborations with stem cell biologists (e.g., Drs. Kieffer and Levings) and engineers (Drs. Turner and Gopaluni) drive innovations in bioprocess optimization and device development. His lab emphasizes multidisciplinary approaches to accelerate biotechnology production processes and cell therapy manufacturing. Awards : William F. Meggers Award (2022) R.S. Jane Memorial Award (2015) Cell Culture Engineering Award (2012) Fellow, Chemical Institute of Canada (2004) His work includes developing novel methodologies for CHO cell glycosylation engineering, optimizing fed-batch bioreactor systems, and advancing Raman spectroscopy techniques for real-time cell analysis. The lab actively recruits motivated graduate and postdoctoral researchers to tackle high-impact challenges in biomedical and chemical engineering.

Christopher Lawsonمشاهده پروفایل

استادیار

• Microbiome Engineering
• Systems Biology
• Synthetic Biology
• +۵ مورد دیگر

Christopher Lawson is an Assistant Professor in the Department of Chemical Engineering and Applied Chemistry at the University of Toronto, affiliated with the Faculty of Applied Science and Engineering. He serves as Principal Investigator of the Microbiome Engineering Lab and is part of BioZone – the Centre for Applied Bioscience and Bioengineering. His research focuses on engineering anaerobic microbiomes for resource recovery from waste streams using systems biology, synthetic biology, and machine learning approaches. B.A.Sc., M.A.Sc. (University of British Columbia) Ph.D. (University of Wisconsin-Madison) Postdoctoral Training (Berkeley Lab) Lawson's work addresses the challenge of controlling complex microbial interactions in engineered systems to enable scalable biotechnologies for renewable energy, chemicals, and materials. His lab develops high-throughput methods integrating automation and computational tools to optimize microbiome assembly and metabolic fluxes. Recent publications highlight advancements in metabolic modeling , isotope tracing , and systems-level analysis of anaerobic microbiomes, with applications in wastewater treatment , anammox granules , and bioenergy production . His research bridges fundamental microbiology with industrial-scale bioprocess engineering. Scientific Awards ISME/IWA BioCluster Rising Star Award (2022) Jacobs Engineering Group/AEESP Outstanding Doctoral Dissertation Award (2020) Wesley Eckenfelder Graduate Research Award (2019) WEF Canham Graduate Studies Scholarship (2018) NSERC Post-Graduate Scholarship – Doctoral (2014) Lawson actively mentors students and postdocs, emphasizing technical rigor, communication skills, and independence. His lab collaborates within BioZone and with industry partners to advance "team science" principles. Current projects focus on creating engineered microbiomes for commercial-scale waste valorization.

• Biomaterials
• Nanomedicine
• Drug Delivery
• +۵ مورد دیگر

Marjo Yliperttula is a Professor at the Department of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki. She serves as a supervisor in the Doctoral Programmes in Biomedicine, Drug Research, and Materials Research and Nanosciences, with expertise in biomaterials and pharmaceutical technology. Her research focuses on nanofibrillated cellulose (NFC) hydrogels for wound healing and drug delivery, extracellular vesicle (EV) engineering for therapeutic applications, and freeze-drying technologies for biomaterial preservation. Key contributions include NFC-based wound dressings that enhance platelet-rich plasma release (2024), Raman spectroscopy methods for monitoring freeze-drying-induced mutarotation (2024), and tandem chromatography techniques for high-purity EV isolation (2023). Her work bridges pharmaceutical sciences with regenerative medicine, emphasizing translational applications in chronic wound treatment and targeted drug delivery. Recent publications (2022-2025) reveal three dominant trends: (1) Optimization of NFC hydrogels for controlled drug release and tissue regeneration, (2) Advanced characterization of EV phenotypes under hypoxic conditions for improved therapeutic efficacy, and (3) Development of analytical methods (Raman spectroscopy, chromatography) to address manufacturing challenges in biopharmaceuticals. These themes reflect her group's commitment to solving critical problems in biomaterial stability, EV-based delivery, and precision wound care. Professor Yliperttula has supervised 10 doctoral theses, including recent work on NFC for skin substitutes (Elle Koivunotko), freeze-drying of hydrogels (Arto Merivaara), and mesenchymal stromal cells for wound healing (Jasmi Snirvi). She currently leads the Academy of Finland-funded GeneCellNa project (2024-2026) on gene/cell/nanotherapy for chronic diseases and a Finnish Red Cross project (2023-2024) on NFC for blood products, with cumulative project funding spanning 18 initiatives since 2005. She heads the Biopharmaceuticals Group within the Drug Research Program, fostering collaborations across pharmaceutical biosciences, materials science, and clinical medicine to advance next-generation therapeutic platforms.

Parth Chansoriaمشاهده پروفایل

مدرس

• Biofabrication
• Tissue Engineering
• Regenerative Medicine
• +۷ مورد دیگر

Dr. Parth Chansoria is a Lecturer at the Department of Health Sciences and Technology at ETH Zürich, where he leads biofabrication research within the Tissue Engineering and Biofabrication (TEB) group. His work focuses on structured light technology for regenerative medicine applications, including in vivo bioprinting and microgravity-based tissue engineering. He holds Ambizione and Spark grants from the Swiss National Science Foundation and has pioneered innovations in light-guided biofabrication, collagen-based resins, and anisotropic tissue design. Research domains include: Filamented light biofabrication for aligned tissues Minimally invasive light-based in vivo bioprinting Musculoskeletal tissue engineering in microgravity Isotonic collagen-based photocrosslinkable resins He has secured over 6 patents and received prestigious awards including the ISBF Early Career Investigator Award (2022), Marie Curie Actions Fellowship (2021), and SME 30 Under 30 recognition (2021). His interdisciplinary research bridges bioengineering, materials science, and clinical applications. Key collaborations include projects at UNC Chapel Hill (USA) and NC State (USA), where he developed biomimetic patches for dynamic organ pathologies and ultrasound-assisted cell patterning. His lab explores novel bioinks, hybrid fabrication techniques, and translational applications in regenerative medicine.

John Bagterp Jørgensenمشاهده پروفایل

استاد

• Model Predictive Control
• Numerical Optimization
• Process Control
• +۵ مورد دیگر

John Bagterp Jørgensen is a Professor at the Department of Applied Mathematics and Computer Science, Technical University of Denmark (DTU). His research focuses on computational methods for Model Predictive Control (MPC), numerical optimization, and dynamic optimization, with applications in industrial processes, biomedical systems, and sustainable energy. He holds leadership roles in 2-control ApS, a company developing advanced control solutions for industries such as cement production and oil recovery. Education: PhD and M.Sc. in Technical Sciences from DTU (1997–2005 and 1991–1997). Professional experience includes roles as an Assistant Professor at DTU and CTO/CEO at 2-control ApS. Research interests span MPC algorithms, numerical methods for differential equations, and system identification. His work bridges academia and industry, addressing challenges in energy efficiency, vaccine manufacturing, diabetes treatment, and cement production processes. His recent articles emphasize industrial applications of control systems, including cement rotary kiln dynamics, vaccine production optimization, and dual-hormone artificial pancreas development. He has received the Nordic Energy Research Award (1994) and contributed to UN Sustainable Development Goals related to affordable energy and industrial innovation. Advising and grants: Supervises multiple PhD projects on topics like electrification of industrial processes and sustainable SCP production. Collaborates with global institutions on energy and biomedical research. Labs/teams: Leads teams in DTU’s Scientific Computing and Center for Energy Resources Engineering, with active partnerships in industry and academia.

Tillman U. Gerngrossمشاهده پروفایل

استاد

• Protein Engineering
• Glycoprotein Engineering
• Biotechnology
• +۳ مورد دیگر

Professor Tillman U. Gerngross is a faculty member at the Thayer School of Engineering at Dartmouth College, where he holds the rank of Professor of Engineering. His research focuses on protein engineering, glycoprotein engineering, and metabolic engineering, with significant contributions to yeast-based production systems for therapeutic proteins. He has pioneered technologies for humanizing glycosylation pathways in yeast, enabling the production of complex glycoproteins for biomedical applications. Education: BS/MS in Chemical Engineering (1989) and PhD in Molecular Biology (1991), both from the Technical University of Vienna, Austria. Research Interests: Professor Gerngross’s work bridges biotechnology and engineering, emphasizing scalable production methods for biologics. His lab has developed novel fermentation and protein expression systems, with applications in antibody engineering and metabolic pathway optimization. Awards: Member of the National Academy of Engineering (2017), 2013 National Academy of Inventors Fellow, and recipient of the 2020 Dartmouth Entrepreneurs Forum Technology Innovation Award. Entrepreneurial Ventures: Co-founder of multiple biotech companies, including GlycoFi (acquired by Merck for $400M), Adimab, Alector, Avitide (acquired by Repligen), and Adagio Therapeutics. These ventures focus on antibody discovery, cancer therapeutics, and pandemic response technologies. Grants & Funding: His startups have secured substantial funding through venture capital and strategic partnerships, reflecting their commercial viability and scientific impact. Notable milestones include Avitide’s $150M acquisition and Alector’s $2.2B valuation post-IPO. Labs & Teams: Leads a multidisciplinary research group at Thayer, collaborating with industry partners to translate academic discoveries into industrial applications. His companies employ advanced R&D teams to develop therapies and biomanufacturing solutions.

• Analytical Chemistry
• Atomic Spectroscopy
• Mass Spectrometry
• +۷ مورد دیگر

R. Kenneth Marcus serves as the Robert Adger Bowen Professor of Chemistry in Clemson University's College of Science Department of Chemistry, where he has maintained an active research program for 38 years. His work bridges analytical instrumentation development and advanced separation science with applications spanning nuclear safeguards to biomedical diagnostics. His academic foundation includes dual Bachelor of Science degrees in Chemistry (with honors) and Physics from Longwood College (1982), followed by a Ph.D. in Chemistry from the University of Virginia (1986). This multidisciplinary training underpins his innovative research approach. Dr. Marcus's research focuses on two synergistic thrusts: (1) plasma-based atomic spectrochemical techniques using glow discharge sources, particularly the liquid sampling-atmospheric pressure glow discharge (LS-APGD) microplasma for optical emission and mass spectrometry; and (2) capillary-channeled polymer (C-CP) fiber stationary phases for high-speed protein and extracellular vesicle separations. Current efforts target field-deployable nuclear safeguards instrumentation and exosome isolation platforms for clinical applications, leveraging commodity polymers like polypropylene and nylon. His 2024-2025 publications reveal a strategic convergence where LS-APGD mass spectrometry enables ultra-high-resolution isotopic analysis for nuclear applications, while C-CP fiber chromatography advances exosome purification across diverse biological matrices. This dual focus positions his work at the intersection of national security needs and emerging biomedical diagnostics. His distinguished recognition includes: Fellow of the Royal Society of Chemistry (2010) Fellow of the American Association for the Advancement of Science (2012) Fellow of the Society for Applied Spectroscopy (2016) Fellow of the National Academy of Inventors (2018) Clemson University Researcher of the Year (2019) South Carolina Governor’s Award for Excellence in Science Research (2001) Dr. Marcus has mentored 44 Ph.D. and 17 M.S. students to completion. His research receives sustained support from the National Nuclear Security Administration (NNSA) through Oak Ridge National Laboratory for nuclear safeguards instrumentation, the National Science Foundation (NSF) for chromatography development, and the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC) for metal speciation studies in bioreactors. His laboratory occupies dedicated spaces (BRC 102, 102A, and 106) within Clemson's AG Biotech/Biosystems Research Complex, housing specialized instrumentation for plasma source development, mass spectrometry coupling, and high-throughput fiber chromatography systems that support collaborative work with nuclear security agencies and biomedical researchers.

G. Kane Jenningsمشاهده پروفایل

استاد

• Smart Surfaces
• Biohybrid Materials
• Solar Energy Conversion
• +۵ مورد دیگر

G. Kane Jennings is a Professor of Chemical and Biomolecular Engineering at Vanderbilt University's School of Engineering, where he also serves as Director of Graduate Recruiting. His research focuses on molecular design of smart surfaces and biohybrid materials for applications in solar energy conversion, responsive coatings, and nanoscale lubrication. He leads the Jennings Lab, training students in bioinspired materials science. Jennings holds a Ph.D. from MIT and specializes in self-assembly techniques and surface-initiated polymerizations. Education: Ph.D., Chemical Engineering, Massachusetts Institute of Technology M.S., Chemical Engineering, Massachusetts Institute of Technology B.S., Chemical Engineering, Auburn University Research Interests: Jennings develops adaptive materials such as anionic chameleon coatings, biohybrid solar systems using Photosystem I proteins, and high-throughput membrane fabrication via spin coating-ROP integration. His group explores nanoscale defect detection in 3D-printed materials and corrosion-resistant surface treatments. Lab Innovations: Highlights include the mMSIP micromolding technique for customizable superhydrophobic coatings and the scROMP method enabling rapid polymer film synthesis. Collaborations with civil engineering and chemistry departments advance energy-minimizing surfaces and bioelectrochemical systems. Awards: No explicit awards listed, though his work has been funded through interdisciplinary initiatives at Vanderbilt's VINSE and Process Innovation Center.

Adam Feinbergمشاهده پروفایل

استاد

• Biomedical Engineering
• Tissue Engineering
• 3D Bioprinting
• +۶ مورد دیگر

Adam Feinberg is a Professor in the Departments of Biomedical Engineering and Materials Science and Engineering at Carnegie Mellon University (CMU). He leads the Regenerative Biomaterials & Therapeutics Group, focusing on cell-material interactions, 3D bioprinting, and bioengineered tissues. His work integrates nanofabrication, molecular biology, and 3D imaging to address challenges in muscle repair, corneal regeneration, and cancer. Key innovations include the FRESH bioprinting platform, enabling soft ECM gel-based constructs, and ECM shrink-wrapping techniques for cell encapsulation. Feinberg holds a Ph.D. and MS in Biomedical Engineering from the University of Florida (2004, 2002) and a BS in Materials Science and Engineering from Cornell University (1999). He has secured major grants, including ARPA-H funding for diabetes treatments and Canada’s New Frontiers Fund for heart disease therapies. His research has led to over 45 peer-reviewed articles and 20 patents. His scientific awards include the NIH Director’s New Innovator Award and NSF CAREER Award. Media highlights include breakthroughs in vascularized tissue models and biodegradable actuators. Feinberg collaborates widely, advancing clinical translation of bioprinted tissues and sustainable bio-bots.